Abiraterone acetate
Abiraterone acetate (pronounced as ab-ee-RA-te-rone AS-e-tate) is a medication used in the treatment of prostate cancer. It is classified under the category of antineoplastic agents, specifically the androgen biosynthesis inhibitors.
Etymology
The term "Abiraterone" is derived from the chemical name 17-(3-Pyridyl)androsta-5,16-dien-3β-ol, where "abi" is short for "androsta-5,16-dien-3β-ol" and "terone" is a common suffix for steroid drugs. The "acetate" part of the name refers to the acetic acid that is combined with abiraterone to make it more soluble and easier for the body to absorb.
Usage
Abiraterone acetate is used in combination with prednisone, a corticosteroid, to treat prostate cancer that has spread to other parts of the body. It is used in men whose cancer cannot be treated with surgery or other medicines.
Mechanism of Action
Abiraterone acetate works by reducing the production of androgens in the body. Androgens are male hormones that can promote tumor growth in the prostate gland.
Related Terms
- Prostate Cancer
- Antineoplastic Agents
- Androgen Biosynthesis Inhibitors
- Steroid
- Androgens
- Corticosteroid
- Prednisone
See Also
External links
- Medical encyclopedia article on Abiraterone acetate
- Wikipedia's article - Abiraterone acetate
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski